A carregar...
Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer
The therapies available for prostate cancer patients whom progress from hormone-sensitive to castration resistant prostate cancer include both systemic drugs, including docetaxel and cabazitaxel, and drugs that inhibit androgen signaling such as enzalutamide and abiraterone. Unfortunately, it is est...
Na minha lista:
| Publicado no: | Asian J Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Second Military Medical University
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477778/ https://ncbi.nlm.nih.gov/pubmed/28642838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajur.2016.08.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|